GE HealthCare Technologies Inc. (NASDAQ: GEHCV) Stock Competitors & Peer Comparison
See GEHCV's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for GEHCV and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| VEEV | $186.24 | +3.71% | 30.3B | 22.37 | $8.33 | N/A |
| GEHC | $60.58 | -2.27% | 27.6B | 13.29 | $4.56 | +0.23% |
| BTSG | $72.91 | +4.40% | 14.3B | 58.80 | $1.24 | N/A |
| BTSGU | $238.26 | +3.48% | 14.2B | 215.44 | $1.11 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $94.64 | +0.32% | 7.9B | 22.11 | $4.28 | N/A |
| TEM | $42.69 | -7.22% | 7.5B | -85.38 | -$0.50 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
| TXG | $46.27 | -3.72% | 5.9B | -272.18 | -$0.17 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
GEHCV vs VEEV Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, VEEV has a market cap of 30.3B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while VEEV trades at $186.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas VEEV's P/E ratio is 22.37. In terms of profitability, GEHCV's ROE is +0.19%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, GEHCV is more volatile compared to VEEV. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
GEHCV vs GEHC Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, GEHC has a market cap of 27.6B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while GEHC trades at $60.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas GEHC's P/E ratio is 13.29. In terms of profitability, GEHCV's ROE is +0.19%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, GEHCV is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check GEHC's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
GEHCV vs BTSG Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, BTSG has a market cap of 14.3B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while BTSG trades at $72.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas BTSG's P/E ratio is 58.80. In terms of profitability, GEHCV's ROE is +0.19%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, GEHCV is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
GEHCV vs BTSGU Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, BTSGU has a market cap of 14.2B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while BTSGU trades at $238.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas BTSGU's P/E ratio is 215.44. In terms of profitability, GEHCV's ROE is +0.19%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, GEHCV is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check BTSGU's competition here
Signify Health, Inc. (NYSE: SGFY)
GEHCV vs SGFY Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SGFY's P/E ratio is 70.91. In terms of profitability, GEHCV's ROE is +0.19%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, GEHCV is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
GEHCV vs HQY Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, HQY has a market cap of 7.9B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while HQY trades at $94.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas HQY's P/E ratio is 22.11. In terms of profitability, GEHCV's ROE is +0.19%, compared to HQY's ROE of +0.11%. Regarding short-term risk, GEHCV is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check HQY's competition here
Tempus AI, Inc. (NASDAQ: TEM)
GEHCV vs TEM Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, TEM has a market cap of 7.5B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while TEM trades at $42.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas TEM's P/E ratio is -85.38. In terms of profitability, GEHCV's ROE is +0.19%, compared to TEM's ROE of -0.70%. Regarding short-term risk, GEHCV is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check TEM's competition here
R1 RCM Inc. (NASDAQ: RCM)
GEHCV vs RCM Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, RCM has a market cap of 6B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas RCM's P/E ratio is -102.21. In terms of profitability, GEHCV's ROE is +0.19%, compared to RCM's ROE of +0.00%. Regarding short-term risk, GEHCV is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
GEHCV vs TXG Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, TXG has a market cap of 5.9B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while TXG trades at $46.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas TXG's P/E ratio is -272.18. In terms of profitability, GEHCV's ROE is +0.19%, compared to TXG's ROE of -0.03%. Regarding short-term risk, GEHCV is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
GEHCV vs HNGE Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, HNGE has a market cap of 5.8B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while HNGE trades at $74.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas HNGE's P/E ratio is 38.12. In terms of profitability, GEHCV's ROE is +0.19%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, GEHCV is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check HNGE's competition here
Doximity, Inc. (NYSE: DOCS)
GEHCV vs DOCS Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, DOCS has a market cap of 3.8B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while DOCS trades at $20.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas DOCS's P/E ratio is 13.35. In terms of profitability, GEHCV's ROE is +0.19%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, GEHCV is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
GEHCV vs ONEM Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas ONEM's P/E ratio is -7.77. In terms of profitability, GEHCV's ROE is +0.19%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, GEHCV is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
GEHCV vs PRVA Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, PRVA has a market cap of 3.2B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while PRVA trades at $25.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas PRVA's P/E ratio is 159.38. In terms of profitability, GEHCV's ROE is +0.19%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, GEHCV is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
GEHCV vs PGNY Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, PGNY has a market cap of 2.4B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while PGNY trades at $31.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas PGNY's P/E ratio is 22.77. In terms of profitability, GEHCV's ROE is +0.19%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, GEHCV is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
GEHCV vs HTFL Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, HTFL has a market cap of 2.1B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while HTFL trades at $24.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas HTFL's P/E ratio is -12.00. In terms of profitability, GEHCV's ROE is +0.19%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, GEHCV is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
GEHCV vs WGS Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, WGS has a market cap of 1.8B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while WGS trades at $59.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas WGS's P/E ratio is 69.53. In terms of profitability, GEHCV's ROE is +0.19%, compared to WGS's ROE of -0.28%. Regarding short-term risk, GEHCV is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check WGS's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
GEHCV vs NXGN Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas NXGN's P/E ratio is -266.00. In terms of profitability, GEHCV's ROE is +0.19%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, GEHCV is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check NXGN's competition here
Teladoc Health, Inc. (NYSE: TDOC)
GEHCV vs TDOC Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, TDOC has a market cap of 1.6B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while TDOC trades at $8.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas TDOC's P/E ratio is -9.75. In terms of profitability, GEHCV's ROE is +0.19%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, GEHCV is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check TDOC's competition here
Agiliti, Inc. (NYSE: AGTI)
GEHCV vs AGTI Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas AGTI's P/E ratio is -71.79. In terms of profitability, GEHCV's ROE is +0.19%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, GEHCV is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check AGTI's competition here
Omada Health (NASDAQ: OMDA)
GEHCV vs OMDA Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, OMDA has a market cap of 1.2B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while OMDA trades at $20.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas OMDA's P/E ratio is 293.29. In terms of profitability, GEHCV's ROE is +0.19%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, GEHCV is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check OMDA's competition here
Certara, Inc. (NASDAQ: CERT)
GEHCV vs CERT Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CERT has a market cap of 1.2B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CERT trades at $7.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CERT's P/E ratio is 19.26. In terms of profitability, GEHCV's ROE is +0.19%, compared to CERT's ROE of -0.01%. Regarding short-term risk, GEHCV is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
GEHCV vs GDRX Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, GDRX has a market cap of 1B. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while GDRX trades at $2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas GDRX's P/E ratio is 8.97. In terms of profitability, GEHCV's ROE is +0.19%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, GEHCV is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check GDRX's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
GEHCV vs CCLDO Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CCLDO's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, GEHCV is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
GEHCV vs HSTM Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, HSTM has a market cap of 792.8M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while HSTM trades at $27.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas HSTM's P/E ratio is 35.70. In terms of profitability, GEHCV's ROE is +0.19%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, GEHCV is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check HSTM's competition here
Phreesia, Inc. (NYSE: PHR)
GEHCV vs PHR Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, PHR has a market cap of 632.6M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while PHR trades at $10.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas PHR's P/E ratio is 36.55. In terms of profitability, GEHCV's ROE is +0.19%, compared to PHR's ROE of +0.03%. Regarding short-term risk, GEHCV is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check PHR's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
GEHCV vs MPLN-WT Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, GEHCV is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
GEHCV vs ACCD Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas ACCD's P/E ratio is -3.08. In terms of profitability, GEHCV's ROE is +0.19%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, GEHCV is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
GEHCV vs SHCR Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SHCR's P/E ratio is -3.76. In terms of profitability, GEHCV's ROE is +0.19%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, GEHCV is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check SHCR's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
GEHCV vs WGSWW Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, WGSWW has a market cap of 514.5M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas WGSWW's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, GEHCV is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check WGSWW's competition here
Evolent Health, Inc. (NYSE: EVH)
GEHCV vs EVH Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, EVH has a market cap of 474.7M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while EVH trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas EVH's P/E ratio is 422.00. In terms of profitability, GEHCV's ROE is +0.19%, compared to EVH's ROE of -0.78%. Regarding short-term risk, GEHCV is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check EVH's competition here
NRC Health (NASDAQ: NRC)
GEHCV vs NRC Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, NRC has a market cap of 474.2M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while NRC trades at $21.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas NRC's P/E ratio is 25.66. In terms of profitability, GEHCV's ROE is +0.19%, compared to NRC's ROE of +0.57%. Regarding short-term risk, GEHCV is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check NRC's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
GEHCV vs SLGC Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SLGC's P/E ratio is -3.04. In terms of profitability, GEHCV's ROE is +0.19%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, GEHCV is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
GEHCV vs SLGCW Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, GEHCV's ROE is +0.19%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, GEHCV is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
GEHCV vs TBRG Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas TBRG's P/E ratio is 9.37. In terms of profitability, GEHCV's ROE is +0.19%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, GEHCV is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check TBRG's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
GEHCV vs SOPH Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SOPH has a market cap of 393.2M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SOPH trades at $5.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SOPH's P/E ratio is -11.00. In terms of profitability, GEHCV's ROE is +0.19%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, GEHCV is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check SOPH's competition here
MultiPlan Corporation (NYSE: MPLN)
GEHCV vs MPLN Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas MPLN's P/E ratio is -0.23. In terms of profitability, GEHCV's ROE is +0.19%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, GEHCV is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
GEHCV vs SLP Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SLP has a market cap of 370.9M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SLP trades at $18.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SLP's P/E ratio is 20.84. In terms of profitability, GEHCV's ROE is +0.19%, compared to SLP's ROE of +0.06%. Regarding short-term risk, GEHCV is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check SLP's competition here
Claritev Corporation (NYSE: CTEV)
GEHCV vs CTEV Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CTEV has a market cap of 369.3M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CTEV trades at $21.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CTEV's P/E ratio is -1.66. In terms of profitability, GEHCV's ROE is +0.19%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, GEHCV is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check CTEV's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
GEHCV vs TRHC Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas TRHC's P/E ratio is -4.27. In terms of profitability, GEHCV's ROE is +0.19%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, GEHCV is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check TRHC's competition here
So-Young International Inc. (NASDAQ: SY)
GEHCV vs SY Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SY has a market cap of 253.2M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SY trades at $1.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SY's P/E ratio is -5.85. In terms of profitability, GEHCV's ROE is +0.19%, compared to SY's ROE of -0.16%. Regarding short-term risk, GEHCV is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check SY's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
GEHCV vs SMFR Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SMFR's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, GEHCV is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
GEHCV vs SPOK Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SPOK has a market cap of 221.2M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SPOK trades at $10.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SPOK's P/E ratio is 17.65. In terms of profitability, GEHCV's ROE is +0.19%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, GEHCV is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
GEHCV vs AMWL Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, AMWL has a market cap of 179.4M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while AMWL trades at $10.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas AMWL's P/E ratio is -2.07. In terms of profitability, GEHCV's ROE is +0.19%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, GEHCV is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
GEHCV vs HCAT Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, HCAT has a market cap of 153.7M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while HCAT trades at $2.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas HCAT's P/E ratio is 10.40. In terms of profitability, GEHCV's ROE is +0.19%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, GEHCV is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
GEHCV vs CPSI Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CPSI's P/E ratio is -183.80. In terms of profitability, GEHCV's ROE is +0.19%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, GEHCV is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
GEHCV vs OPRX Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, OPRX has a market cap of 117.1M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while OPRX trades at $6.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas OPRX's P/E ratio is 5.72. In terms of profitability, GEHCV's ROE is +0.19%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, GEHCV is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
GEHCV vs AUGX Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas AUGX's P/E ratio is -4.99. In terms of profitability, GEHCV's ROE is +0.19%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, GEHCV is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
GEHCV vs CCLD Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CCLD has a market cap of 94.3M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CCLD trades at $2.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CCLD's P/E ratio is 8.22. In terms of profitability, GEHCV's ROE is +0.19%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, GEHCV is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
GEHCV vs DH Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, DH has a market cap of 72.4M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while DH trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas DH's P/E ratio is 2.64. In terms of profitability, GEHCV's ROE is +0.19%, compared to DH's ROE of -0.67%. Regarding short-term risk, GEHCV is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
GEHCV vs FORA Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas FORA's P/E ratio is -24.11. In terms of profitability, GEHCV's ROE is +0.19%, compared to FORA's ROE of -0.17%. Regarding short-term risk, GEHCV is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
GEHCV vs CCLDP Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CCLDP's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, GEHCV is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
GEHCV vs ONMD Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, ONMD has a market cap of 35M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while ONMD trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas ONMD's P/E ratio is -4.10. In terms of profitability, GEHCV's ROE is +0.19%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, GEHCV is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
GEHCV vs SNCE Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SNCE's P/E ratio is -0.27. In terms of profitability, GEHCV's ROE is +0.19%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, GEHCV is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
GEHCV vs AKLI Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas AKLI's P/E ratio is -0.71. In terms of profitability, GEHCV's ROE is +0.19%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, GEHCV is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
GEHCV vs SHLT Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SHLT's P/E ratio is -3.87. In terms of profitability, GEHCV's ROE is +0.19%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, GEHCV is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
GEHCV vs SHCRW Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, GEHCV's ROE is +0.19%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, GEHCV is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check SHCRW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
GEHCV vs EUDA Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, EUDA has a market cap of 28M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while EUDA trades at $14.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas EUDA's P/E ratio is -28.30. In terms of profitability, GEHCV's ROE is +0.19%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, GEHCV is more volatile compared to EUDA. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check EUDA's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
GEHCV vs ONMDW Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, ONMDW has a market cap of 27.8M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas ONMDW's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, GEHCV is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
GEHCV vs STRM Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas STRM's P/E ratio is -2.40. In terms of profitability, GEHCV's ROE is +0.19%, compared to STRM's ROE of -0.32%. Regarding short-term risk, GEHCV is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
GEHCV vs RNLX Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas RNLX's P/E ratio is -0.33. In terms of profitability, GEHCV's ROE is +0.19%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, GEHCV is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
GEHCV vs LIFW Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas LIFW's P/E ratio is -0.02. In terms of profitability, GEHCV's ROE is +0.19%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, GEHCV is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check LIFW's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
GEHCV vs BEATW Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, BEATW has a market cap of 15.9M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while BEATW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas BEATW's P/E ratio is -0.04. In terms of profitability, GEHCV's ROE is +0.19%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, GEHCV is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check BEATW's competition here
Babylon Holdings Limited (NYSE: BBLN)
GEHCV vs BBLN Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas BBLN's P/E ratio is -0.04. In terms of profitability, GEHCV's ROE is +0.19%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, GEHCV is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check BBLN's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
GEHCV vs ETAO Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas ETAO's P/E ratio is -0.01. In terms of profitability, GEHCV's ROE is +0.19%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, GEHCV is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
GEHCV vs BFRG Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, BFRG has a market cap of 7.1M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while BFRG trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas BFRG's P/E ratio is -1.12. In terms of profitability, GEHCV's ROE is +0.19%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, GEHCV is more volatile compared to BFRG. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check BFRG's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
GEHCV vs SCNX Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, SCNX has a market cap of 5.7M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while SCNX trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas SCNX's P/E ratio is -0.15. In terms of profitability, GEHCV's ROE is +0.19%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, GEHCV is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
GEHCV vs UPH Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas UPH's P/E ratio is -0.07. In terms of profitability, GEHCV's ROE is +0.19%, compared to UPH's ROE of -1.05%. Regarding short-term risk, GEHCV is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
GEHCV vs UPH-WT Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, GEHCV is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check UPH-WT's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
GEHCV vs MGRX Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, MGRX has a market cap of 5.3M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while MGRX trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas MGRX's P/E ratio is -0.39. In terms of profitability, GEHCV's ROE is +0.19%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, GEHCV is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
GEHCV vs PEAR Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas PEAR's P/E ratio is -0.08. In terms of profitability, GEHCV's ROE is +0.19%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, GEHCV is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
GEHCV vs PEARW Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas PEARW's P/E ratio is -0.00. In terms of profitability, GEHCV's ROE is +0.19%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, GEHCV is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
GEHCV vs OTRK Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas OTRK's P/E ratio is -0.02. In terms of profitability, GEHCV's ROE is +0.19%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, GEHCV is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check OTRK's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
GEHCV vs HCTI Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, HCTI has a market cap of 1.9M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while HCTI trades at $1.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas HCTI's P/E ratio is -0.21. In terms of profitability, GEHCV's ROE is +0.19%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, GEHCV is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
GEHCV vs CMAX Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CMAX's P/E ratio is -0.00. In terms of profitability, GEHCV's ROE is +0.19%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, GEHCV is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CMAX's competition here
Aclarion, Inc. (NASDAQ: ACON)
GEHCV vs ACON Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while ACON trades at $2.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas ACON's P/E ratio is -0.23. In terms of profitability, GEHCV's ROE is +0.19%, compared to ACON's ROE of -0.54%. Regarding short-term risk, GEHCV is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check ACON's competition here
VSee Health, Inc. (NASDAQ: VSEE)
GEHCV vs VSEE Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, VSEE has a market cap of 1.3M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while VSEE trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas VSEE's P/E ratio is -0.15. In terms of profitability, GEHCV's ROE is +0.19%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, GEHCV is more volatile compared to VSEE. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check VSEE's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
GEHCV vs VSEEW Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, VSEEW has a market cap of 1.3M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, GEHCV's ROE is +0.19%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, GEHCV is more volatile compared to VSEEW. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
GEHCV vs LIFWZ Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, GEHCV is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
GEHCV vs EUDAW Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, EUDAW has a market cap of 922.5K. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, GEHCV's ROE is +0.19%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, GEHCV is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
GEHCV vs WORX Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, WORX has a market cap of 629.5K. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while WORX trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas WORX's P/E ratio is -0.69. In terms of profitability, GEHCV's ROE is +0.19%, compared to WORX's ROE of -0.65%. Regarding short-term risk, GEHCV is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
GEHCV vs MSPRZ Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, GEHCV is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
GEHCV vs KERN Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas KERN's P/E ratio is -0.01. In terms of profitability, GEHCV's ROE is +0.19%, compared to KERN's ROE of -0.17%. Regarding short-term risk, GEHCV is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
GEHCV vs KERNW Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas KERNW's P/E ratio is -0.00. In terms of profitability, GEHCV's ROE is +0.19%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, GEHCV is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
GEHCV vs LIFWW Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas LIFWW's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, GEHCV is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
GEHCV vs ZCMD Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, ZCMD has a market cap of 48.6K. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while ZCMD trades at $1.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas ZCMD's P/E ratio is -0.05. In terms of profitability, GEHCV's ROE is +0.19%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, GEHCV is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
GEHCV vs CMAXW Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CMAXW's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, GEHCV is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
GEHCV vs ACONW Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, ACONW has a market cap of 11.9K. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas ACONW's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, GEHCV is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check ACONW's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
GEHCV vs MTBCO Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas MTBCO's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, GEHCV is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check MTBCO's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
GEHCV vs AFFX Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, AFFX has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas AFFX's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, GEHCV is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check AFFX's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
GEHCV vs MTBCP Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas MTBCP's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, GEHCV is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
GEHCV vs MTBC Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, MTBC has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas MTBC's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, GEHCV is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
GEHCV vs CHNG Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CHNG has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CHNG's P/E ratio is -152.72. In terms of profitability, GEHCV's ROE is +0.19%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, GEHCV is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CHNG's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
GEHCV vs CHNGU Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CHNGU's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, GEHCV is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CHNGU's competition here
Cue Health Inc. (NASDAQ: HLTH)
GEHCV vs HLTH Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, HLTH has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while HLTH trades at $25.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas HLTH's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to HLTH's ROE of +0.00%. Regarding short-term risk, GEHCV is more volatile compared to HLTH. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check HLTH's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
GEHCV vs CNVY Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CNVY has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CNVY's P/E ratio is -71.50. In terms of profitability, GEHCV's ROE is +0.19%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, GEHCV is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CNVY's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
GEHCV vs NAVA Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, NAVA has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas NAVA's P/E ratio is N/A. In terms of profitability, GEHCV's ROE is +0.19%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, GEHCV is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for GEHCV.Check NAVA's competition here
Cerner Corporation (NASDAQ: CERN)
GEHCV vs CERN Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CERN has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CERN's P/E ratio is 55.84. In terms of profitability, GEHCV's ROE is +0.19%, compared to CERN's ROE of +0.14%. Regarding short-term risk, GEHCV is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CERN's competition here
Castlight Health, Inc. (NYSE: CSLT)
GEHCV vs CSLT Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, CSLT has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas CSLT's P/E ratio is -37.27. In terms of profitability, GEHCV's ROE is +0.19%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, GEHCV is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for GEHCV.Check CSLT's competition here
NantHealth, Inc. (NASDAQ: NH)
GEHCV vs NH Comparison July 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHCV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHCV stands at 25.5B. In comparison, NH has a market cap of 0. Regarding current trading prices, GEHCV is priced at $56.00 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHCV currently has a P/E ratio of N/A, whereas NH's P/E ratio is -0.12. In terms of profitability, GEHCV's ROE is +0.19%, compared to NH's ROE of +0.35%. Regarding short-term risk, GEHCV is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for GEHCV.Check NH's competition here